Anti-Human IL17A Recombinant Antibody(Secukinumab)
-
产品编号
YR1220
-
别名
科研级 Secukinumab ( 司库奴单抗 ), Anti-IL17A Recombinant Antibody, Research Grade Secukinumab
-
规格
- 1mg
- 5mg
| Catalog Number | YR1220 |
| Alias | 科研级 Secukinumab ( 司库奴单抗 ), Anti-IL17A Recombinant Antibody, Research Grade Secukinumab |
| Size | 1mg, 5mg |
| Molecular Name | Secukinumab |
| CAS Number | 1229022-83-6 |
| Molecular Weight | 147.94 kDa |
| Target | IL17A[Homo sapiens] |
| Antibody Isotype | IgG1 Kappa |
| Clonity | Monoclonal |
| Concentration | 1mg/ml |
| Purity | >95% as determined by SDS-PAGE |
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Formulation | PBS, pH7.5 |
| Shipping Condition | Shipped on ice packs. |
| Background | Secukinumab, sold under the brand name Cosentyx, is a human IgG1κ monoclonal antibody that binds to the protein interleukin (IL)-17A, and is marketed by Novartis for the treatment of psoriasis, ankylosing spondylitis, and psoriatic arthritis. It inhibits a member of the cytokine family, interleukin 17A. |
| Remarks | This product is for research use only. |
0